Ocumension Therapeutics (HKG:1477)
Hong Kong · Delayed Price · Currency is HKD 5.33
-0.19 (-3.35%)
Sep 11, 2026, 4:08 PM HKT
Ocumension Therapeutics Market Cap
Ocumension Therapeutics has a market cap or net worth of 4.5 billion as of September 10, 2026. Its market cap has decreased by -44.68% in one year.
Market Cap
4.50B
Enterprise Value
4.52B
Revenue
1.08B
Ranking
n/a
PE Ratio
n/a
Stock Price
5.33
ChartMarket Cap Chart
Since July 10, 2020, Ocumension Therapeutics's market cap has decreased from 21.28B to 4.50B, a decrease of -78.87%. That is a compound annual growth rate of -22.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 4.35B | -27.97% |
| Dec 31, 2025 | 6.03B | 64.39% |
| Dec 31, 2024 | 3.67B | -20.44% |
| Dec 29, 2023 | 4.61B | -30.21% |
| Dec 30, 2022 | 6.61B | -43.35% |
| Dec 31, 2021 | 11.67B | -26.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Abbisko Cayman | 5.94B |
| CK Life Sciences Int'l., (Holdings) | 5.38B |
| Shanghai Bao Pharmaceuticals | 5.21B |
| Jacobio Pharmaceuticals Group | 4.79B |
| Hanx Biopharmaceuticals (Wuhan) | 3.96B |
| TransThera Sciences (Nanjing) | 3.95B |
| Qyuns Therapeutics | 3.69B |
| Mirxes Holding Company | 3.66B |